What is the difference between Herpes antibody and Herpes 1/2 IgG (Immunoglobulin G) testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Difference Between Herpes Antibody and Herpes 1/2 IgG Testing

Herpes 1/2 IgG testing is a specific type of herpes antibody test that detects type-specific glycoprotein G antibodies to differentiate between HSV-1 and HSV-2 infections, while general herpes antibody tests may not distinguish between virus types. 1

Key Differences and Testing Methods

Herpes Antibody Testing (General)

  • Refers to any serologic test that detects antibodies against herpes simplex virus
  • May include tests for different antibody types (IgG, IgM, IgA)
  • May not differentiate between HSV-1 and HSV-2
  • Includes older, less specific methods that detect antibodies to various viral proteins

Herpes 1/2 IgG Testing (Type-Specific)

  • Specifically detects IgG antibodies against glycoprotein G-1 (gG-1) or glycoprotein G-2 (gG-2)
  • Allows differentiation between HSV-1 and HSV-2 infections
  • Available as:
    • Enzyme immunoassay (EIA)
    • Chemiluminescent immunoassay (CLIA)
    • Immunoblot tests
  • Sensitivity for HSV-2 is approximately 92% 1

Clinical Applications and Limitations

When to Use Type-Specific Serology (HSV-1/2 IgG)

  • Detecting asymptomatic infections
  • Testing pregnant women at risk of acquiring HSV near delivery
  • Testing men who have sex with men
  • Testing people who are HIV positive 1

Limitations of Type-Specific Testing

  • False negatives occur in 12-30% of patients with recurrent HSV-1 or HSV-2 DNA positive genital lesions 2
  • HSV-1 serologic tests may have sensitivity as low as 70.2% 1
  • HSV-2 serologic tests may lack specificity, particularly with low index values 1
  • A single test may miss infections; using multiple tests improves detection 2

Preferred Testing Approaches

First-Line Testing for Symptomatic Patients

  • For patients with active lesions, PCR/NAAT from lesion specimens is preferred over antibody testing
  • PCR has highest sensitivity and specificity (>90%)
  • Can differentiate between HSV-1 and HSV-2
  • Provides results within approximately two hours 1

Timing of Antibody Testing

  • Wait at least 12 weeks after suspected exposure before antibody testing 1
  • IgM testing can help detect early seroconversion before IgG develops 3
  • IgG antibodies persist long-term and indicate past or current infection

Interpreting Results

IgG Antibody Results

  • Positive: Indicates current or past infection with the specific HSV type
  • Negative: May indicate no infection OR false negative (especially early in infection)
  • IgG1 antibodies are typically the first to appear in primary infections 4

IgM Antibody Results

  • Can indicate recent infection if IgG is negative
  • However, IgM is also detected in a large proportion of patients with established HSV-2 infection (29-33%) 3
  • Adding IgM testing to IgG testing increases detection of early HSV-2 infection from 40-47% to 70% 3

Common Pitfalls to Avoid

  • Relying on a single antibody test when clinical suspicion is high (consider using multiple test formats) 2
  • Testing too early after exposure (before antibodies develop)
  • Misinterpreting positive IgM as always indicating recent infection 3
  • Failing to consider PCR testing when lesions are present
  • Not recognizing that type-specific tests may miss 12-30% of confirmed infections 2

Remember that the World Health Organization and the American College of Physicians recommend against widespread screening for genital herpes in asymptomatic individuals 1.

References

Guideline

Laboratory Diagnosis and Management of Herpesviruses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006

Research

IgG subclass antibodies to herpes simplex virus.

The Journal of infectious diseases, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.